eClinical Solutions Welcomes Sean Lannan as Chief Financial Officer

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced the appointment of Sean Lannan as Chief Financial Officer (CFO). In this role, Lannan will provide strategic operational and financial direction for eClinical Solutions as the company focuses on reducing cycle times for biopharma through innovation, including the adoption of risk-based strategies and artificial intelligence (AI). Additionally, Jason Blessing has recently joined the Board of Directors and will help further drive the company’s strategy and maximize value for customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515969255/en/

“Sean is a veteran industry leader with deep expertise in fueling sustainable growth. We’re thrilled to welcome him to our executive leadership team, and his track record in scaling technology companies will be invaluable as we broaden the impact of our elluminate^® platform and help our customers accelerate clinical research,” said Raj Indupuri, CEO and co-founder of eClinical Solutions. “The industry is at a pivotal moment when biopharma cycle times have become the new currency. Both Sean and Jason’s unique experiences will be critical in scaling our business, deepening our AI capabilities, and forging strong partnerships as we demonstrate the ROI of data-driven processes for future-proof digital trials.”

Lannan brings over 30 years of global experience across the technology field, driving financial strategy and transformation in areas including healthcare, education, and digital experience management. Lannan holds a Master of Business Administration in Finance and Entrepreneurial Management from Wharton, and a Bachelor of Arts in Economics and Political Science from Yale. He joins eClinical Solutions after serving as a strategic CFO consultant to institutional growth investors, including private equity and venture capital. Before that, Lannan was CFO at Litmos, where he was a founding member of the executive team, leading finance, accounting, and go-to-market activities.

“I look forward to bringing my hands-on, big-picture, and detailed financial approach to eClinical Solutions as the company looks to empower innovation, helping to drive the next breakthrough in the life sciences industry,” said Lannan. “My background working with technology-inspired businesses will be key in propelling the financial health of eClinical Solutions, ensuring the company is positioned to effectively help customers manage trial complexity in less time and with fewer resources.”

In his role at eClinical Solutions, Lannan will focus on scaling global finance operations and guiding strategic capital allocation—including selective M&A to complement organic growth. Lannan’s background in building lean and effective finance, human resources, and legal teams and implementing internal systems to scale profitable growth makes him especially well-suited for this role.

Additionally, Blessing, a transformational CEO, advisor, and investor with over three decades of software experience, has joined the company’s Board of Directors during a time of rapid growth for eClinical Solutions. Blessing has a proven track record of building teams that drive significant stakeholder value, while fostering award-winning work environments. Lannan and Blessing’s appointments follow a strong 2024 that included signing 20 net new clients and 34% YoY software growth, with eClinical now serving 16 of the top 50 pharmaceutical companies in the world. Within the last year, eClinical Solutions also strengthened the strategic leadership team, helping to position the company for ongoing success in accelerating research and driving tomorrow’s therapeutic breakthroughs.

To learn more about eClinical Solutions, visit the website here: https://www.eclinicalsol.com/

About eClinical Solutions

eClinical Solutions’ industry-leading data & analytics platform, elluminate®, and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations manage trial complexity in less time and with fewer resources. Clients get accurate and timely data insights for better decision-making – enabling them to reduce cycle times, improve productivity, easily scale, and develop tomorrow’s breakthroughs with today’s resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplaces Culture Excellence Award, 2024 Top Workplaces USA Award, and Great Place To Work® India Certification™. Learn more at www.eclinicalsol.com and follow eClinical Solutions on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250515969255/en/